My Events

9th Preventive Cardiology Conference: Dysmetabolic Obesity

Katie Smith — Sat, 18 Feb 2012 7:10:47 EST

Course Director: V. S. Murthy, MBBS, MD, PhD â�¢ Identify the contributions of individual, family and societal factors in the development of overweight and obese subjects. â�¢ Describe how to manage the patients with proactive, education and counseling incorporating integrative care, patient preferences and priorities. â�¢ Explain simple ways of counseling overweight and obese subjects in their clinic and when feasible, by alternative methods (telemedicine) to enhance compliance. â�¢ Review the healthy food groups and their role in a healthy meal plan.

CVD Prevention: 10th Annual Comprehensive Symposium

Katie Smith — Thu, 23 Feb 2012 12:00:00 EST

A key strategy for addressing heart disease and stroke is to educate the public and healthcare practitioners about the importance of prevention. When healthcare providers perform consistent risk factor assessments, more patients can be properly diagnosed and medically managed to prevent cardiovascular disease. Both primary and secondary prevention, as well as new developments in the diagnosis, treatment and prevention of cardiovascular disease, need to be addressed.

NLA Spring 2012 Clinical Lipid Update

Katie Smith — Fri, 9 Mar 2012 8:00:00 EST

Hosted by MWLA and PLA Hilton Bayfront San Diego, CA

4th Annual Central California Cardiometabolic Risk Symposium

Katie Smith — Sat, 17 Mar 2012 8:00:22 EDT

Sponsored by the Saint Agnes Medical Center, Fresno, CA Contact: delphine.boss@samc.com CME provided by IMQ (Institute for Medical Quality)

XVI International Symposium on Atherosclerosis

Amy Waller — Sun, 25 Mar 2012 8:01:53 EDT

The program provides a comprehensive, state-of-the-art overview of the current understanding of the origins, progression and prevention of atherosclerosis.

High-density Lipoproteins: Biology and Therapeutics

Amy Waller — Fri, 30 Mar 2012 14:15:41 EDT

The symposium â��High-density lipoproteins: biology and therapeuticsâ�� is a satellite of the XVIth International Symposium on Atherosclerosis (Sydney 2012). It will be held on 30 March - 1 April 2012 in Cairns, Tropical North Queensland, Australia. The objective of the symposium is to provide a forum for presentation and discussion of state-of-the-art knowledge of the biology and biochemistry of high-density lipoprotein (HDL) and recent developments in therapeutics relying on modifications of HDL metabolism.

PCNA Annual Symposium

Amy Waller — Thu, 12 Apr 2012 11:40:38 EDT

Designed to blend the latest advancements in science with practical clinical approaches to patient management, the Preventive Cardiac Nurses Association (PCNA) Annual Symposium features keynote addresses, lectures and workshops presented by world-renowned authorities in cardiovascular risk reduction and disease management.

CVD Prevention for Woman

Amy Waller — Sat, 28 Apr 2012 16:01:21 EDT

Join the American Society for Preventive Cardiology (ASPC) for a one-day symposium that will focus on cardiovascular disease prevention and treatment strategies for women. A special live case presentation on the Hidden Risk Patient: Women with FH-Underdiagnosed and Undertreated will offer attendees a first-hand experience of a seemingly healthy woman battling Familial Hypercholesterolemia.

ASH 2012 Annual Meeting

Amy Waller — Sat, 19 May 2012 11:51:28 EDT

The American Society of Hypertension 2012 Annual Scientific Meeting & Exposition will be held on Saturday, May 19 - Tuesday, May 22, 2012 at the Hilton New York City.

NLA 2012 Annual Scientific Sessions

Katie Smith — Thu, 31 May 2012 8:00:05 EDT

Hosted by SWLA May 31-June 3 J.W. Marriott Scottsdale, AZ

1st International Conference on FH

Amy Waller — Fri, 8 Jun 2012 11:06:29 EDT

You are invited to attend the 1st International Conference on Familial Hypercholesterolaemia in Children & Adolescents, in Athens, Greece, 8-9 June 2012. Topics to be discussed cover the whole spectrum of FH, starting with the genetics and clinical presentation of the condition, overviewing nutritional and drug treatment approaches and, last but not least, enumerating current and future strategies and perspectives in both treatment and prevention.

NLA Fall 2012 Clinical Lipid Update

Katie Smith — Fri, 14 Sep 2012 8:00:12 EDT

Hosted by SELA and NELA Charlotte Westin Charlotte, NC